Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Elomaa

Showing results (71-80 of 143) with videos related to

Pageof 15
Sort By:
World Journal of Surgery|March 1, 1983
Hyperparathyroidism with hypercalciuria and urolithiasis: long-term effects of parathyroid surgery and postoperative thiazide therapyI Elomaa, A Sivula, A Kahri, et al.
British Journal of Cancer|April 20, 2001
The effect of clodronate and antioestrogens on bone loss associated with oestrogen withdrawal in postmenopausal women with breast cancerT Saarto, L Vehmanen, I Elomaa, et al.
British Journal of Cancer|January 1, 1997
Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogensT Saarto, C Blomqvist, M Välimäki, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Impact of chemotherapy on collagen metabolism: a study of serum PIIINP (aminoterminal propeptide of type III procollagen) in advanced sarcomasT A Wiklund, C P Blomqvist, L Risteli, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Comparative effects of clodronate and calcitonin on bone in metastatic breast cancer: a histomorphometric studyT Taube, I Elomaa, C Blomqvist, et al.
British Journal of Cancer|July 2, 1998
Demonstration of increased collagen synthesis in irradiated human skin in vivoP Autio, T Saarto, M Tenhunen, et al.
British Journal of Cancer|January 1, 1996
Type I and type III collagen metabolites in adult osteosarcoma patientsT Wiklund, C Blomqvist, L Risteli, et al.
Bone|January 1, 1987
Treatment of skeletal disease in breast cancer: a controlled clodronate trialI Elomaa, C Blomqvist, L Porkka, et al.
British Journal of Cancer|July 31, 1998
Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patientsT Saarto, C Blomqvist, J Risteli, et al.
British Journal of Cancer|February 1, 1992
Type III collagen metabolism in soft tissue sarcomasT A Wiklund, I Elomaa, C P Blomqvist, et al.
Pageof 15

Showing results (71-80 of 143) with videos related to

Sort By:
Pageof 15
World Journal of Surgery|March 1, 1983
Hyperparathyroidism with hypercalciuria and urolithiasis: long-term effects of parathyroid surgery and postoperative thiazide therapyI Elomaa, A Sivula, A Kahri, et al.
British Journal of Cancer|April 20, 2001
The effect of clodronate and antioestrogens on bone loss associated with oestrogen withdrawal in postmenopausal women with breast cancerT Saarto, L Vehmanen, I Elomaa, et al.
British Journal of Cancer|January 1, 1997
Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogensT Saarto, C Blomqvist, M Välimäki, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Impact of chemotherapy on collagen metabolism: a study of serum PIIINP (aminoterminal propeptide of type III procollagen) in advanced sarcomasT A Wiklund, C P Blomqvist, L Risteli, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Comparative effects of clodronate and calcitonin on bone in metastatic breast cancer: a histomorphometric studyT Taube, I Elomaa, C Blomqvist, et al.
British Journal of Cancer|July 2, 1998
Demonstration of increased collagen synthesis in irradiated human skin in vivoP Autio, T Saarto, M Tenhunen, et al.
British Journal of Cancer|January 1, 1996
Type I and type III collagen metabolites in adult osteosarcoma patientsT Wiklund, C Blomqvist, L Risteli, et al.
Bone|January 1, 1987
Treatment of skeletal disease in breast cancer: a controlled clodronate trialI Elomaa, C Blomqvist, L Porkka, et al.
British Journal of Cancer|July 31, 1998
Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patientsT Saarto, C Blomqvist, J Risteli, et al.
British Journal of Cancer|February 1, 1992
Type III collagen metabolism in soft tissue sarcomasT A Wiklund, I Elomaa, C P Blomqvist, et al.
Pageof 15